Non-Tethered Organometallic Phosphonate Inhibitors for Lipase Inhibition
fractions were dried with MgSO4. The mixture was filtered, the
filtrate concentrated to 2 mL and pentane was added to precipitate
the product as an off-white solid. Yield: 0.64 g (92%). 1H NMR
4-Bromoplatinum{3,5-bis[(dimethylamino)methyl]phenyl}phosphonic
Acid (4): The same procedure as that for 3 was applied: 10 (100 mg,
0.17 mmol), bromotrimethylsilane (252 mg, 218 µL, 1.66 mmol) in
3
3
(CDCl3): δ = 7.06 (d, JH,P = 12.82 Hz, 2 H, ArH), 3.96 (s, JH,Pt CH2Cl2 (5 mL), MeOH (8 mL), and dichloromethane (2 mL) were
3
3
= 46.88 Hz, 4 H, CH2N), 3.92 (m, CH2O, 2 H), 3.03 [s, JH,Pt
=
used. Yield: 85 mg (94%). 1H NMR (D2O): δ = 7.13 (d, JH,P
=
3
3
38.09 Hz, 12 H, N(CH3)2], 2.61 [d, JHP = 8.06 Hz, 6 H, PN- 13.2 Hz, 2 H, ArH), 4.04 (s, JH,Pt = 43.9 Hz, 4 H, CH2), 2.89 (s,
(CH3)2], 1.21 (t, 3JH,H = 6.96 Hz, 3 H, CH3CH2O) ppm. 31P NMR 3JH,Pt = 36.2 Hz, 12 H, NMe2) ppm. 31P NMR (D2O): δ = 19.01
(CDCl3): δ = 27.63 (s) ppm. 13C NMR (CDCl3): δ = 152.9 (d, 4JC,P (s) ppm. 13C NMR (D2O): δ = 161.5 (s, ArC), 149.1 (d, JC,P
=
=
3
3
1
1
2
= 2.3 Hz, ArC), 144.0 (d, JC,P = 15.2 Hz), 125.0 (d, JC,P
=
16.8 Hz, ArC), 125.4 (d, JC,P = 176.9 Hz, ArC), 121.8 (d, JC,P
1
2
3
175.0 Hz, ArC), 125.0 (d, JC,P = 175.0 Hz, ArC), 122.46 (d, JC,P
= 10.4, JC,Pt = 17.3 Hz, ArC), 77.4 (s, ArCH2N), 60.4 (d, JC,P
6.1 Hz, CH2O), 55.3 [s, N(CH3)2], 36.7 [d, JC,P = 4.2 Hz,
11.6 Hz, ArC), 76.3 (s, JC,Pt = 41.6 Hz, CH2), 54.4 [s, N(CH3)2]
3
2
=
ppm.
2
Supporting Information (see footnote on the first page of this arti-
cle): Crystallographic data of the crystal structures complexes 9 and
10.
3
PN(CH3)2], 16.6 (d, JC,P
=
6.7 Hz, CH3CH2O) ppm.
C16H29ClN3O2PPt (556.93): calcd. C 34.51, H 5.25, N 7.54; found
C 34.62, H 5.28, N 7.48.
Ethyl 4-Nitrophenyl P-{4-Chloroplatinum-3,5-bis[(dimethylamino)-
methyl]phenyl}phosphonate (2): A solution of compound 8 (200 mg,
3.59 mmol) in benzene (20 mL) was treated dropwise with anhy-
drous HCl (1 in Et2O, 1.8 mL, 1.8 mmol, 5 equiv.) and afterwards
the mixture was stirred for 3 h. The formed turbid mixture was
filtered under a N2 atmosphere, and a clear yellow solution was
collected as filtrate. The filtrate was concentrated in vacuo to a
yellowish solid. The solid residue was redissolved in benzene
(20 mL) and dry NEt3 (36.3 mg, 50 µL, 3.59 mmol) was added to
the mixture, followed by the dropwise addition of a solution of p-
nitrophenol (50 mg, 3.59 mmol) in benzene (20 mL). Slowly, a tur-
bid mixture was formed while the reaction mixture was stirred for
one hour at room temperature. After filtration of the reaction mix-
ture under a N2 atmosphere, a saturated NaHCO3 solution (20 mL)
was added. The organic phase was separated and washed with a
saturated NaHCO3 solution (2ϫ20 mL) followed by water
(20 mL). The product-containing organic phase was dried with
MgSO4, filtered, and concentrated to a pale yellow solid. Yield:
Acknowledgments
The authors kindly wish to thank C. Versluis and Prof. A. J. R.
Heck of the Biomolecular Mass Spectrometry group in the Depart-
ment of Pharmaceutical Sciences at Utrecht University for measur-
ing the ESI-MS spectra of various protein structures. This work
was supported by the Council for Chemical Sciences of the Dutch
organization for Scientific Research (CW-NWO) . The Unilever Re-
search Laboratory at Vlaardingen in The Netherlands, is kindly
acknowledged for the enzyme supply.
[1] a) J. Kraut, Ann. Rev. Biochem. 1977, 46, 331–358; b) P. E. Kol-
attukudy in Lipases, Elsevier, Amsterdam, 1984, 471–501; c) S.
Ransac, Y. Gargouri, F. Marguet, G. Buono, C. Beglinger, P.
Hildebrand, H. Lengsfeld, P. Hadvary, R. Verger, Methods En-
zymol. 1997, 286, 190–231.
[2] a) O. V. Oskolkova, R. Saf, E. Zenzmaier, A. Hermetter, Chem.
Phys. Lipids 2003, 125, 103–114; b) H. Schmidinger, R. Birner-
Gruenberger, G. Riesenhuber, R. Saf, H. Susani-Etzerodt, A.
Hermetter, ChemBioChem 2005, 6, 1776–1781; c) G. Zan-
donella, P. Stadler, L. Haalck, F. Spener, F. Paltauf, A. Her-
metter, Eur. J. Biochem. 1999, 262, 63–69.
[3] C. M. Salisbury, J. Ellman, ChemBioChem 2006, 7, 1034–1037.
[4] a) N. Jessani, J. A. Young, S. L. Diaz, M. P. Patricelli, A. Varki,
B. F. Cravatt, Angew. Chem. Int. Ed. 2005, 44, 2400–2403; b)
A. E. Speers, B. F. Cravatt, ChemBioChem 2004, 5, 41–47; c)
H. Schmidinger, H. Susani-Etzerodt, R. Birner-Gruenberger,
A. Hermetter, ChemBioChem 2006, 7, 527–534.
[5] It should be noted that the hydrolytic sensitivity of the SerO–
P bond is dependent upon the nature of R1 (Figure 1). If for
example R1 = p-nitrophenyl, the SerO–P bond is easily hy-
drolyzed, thereby releasing the phosphonate group from the
protein again (see ref.[7]). For the phosphonate inhibitors de-
scribed in this paper with R1 = Et, no observable hydrolysis
occurred for at least two weeks.
[6] a) C. A. Kruithof, G. Guillena, M. R. Egmond, G. van Koten
in Book of Abstracts, First International Symposium on Bioor-
ganometallic Chemistry, 18–20 July 2002, Paris, p. 104; b) C. A.
Kruithof, M. A. Casado, G. Guillena, M. R. Egmond, A.
van der Kerk-van Hoof, A. J. R. Heck, R. J. M. Klein Geb-
bink, G. van Koten, Chem. Eur. J. 2005, 11, 6869–6877.
[7] It should be stated that Reetz and co-workers were the first to
publish the concept of site-specific introduction of metal–li-
gand systems into lipases via phosphonate inhibitors. Their ex-
amples, however, did not result in irreversible protein modifica-
tion because of fast hydrolysis of the SerO–P bond (see also
ref.[5]): see M. T. Reetz, M. Rentzsch, A. Pletsch, M. Maywald,
Chimia 2002, 56, 721–723.
1
3
187 mg (80%). H NMR (C6D6): δ = 7.74 (d, JH,H = 9.16 Hz, 2
3
3
H, ArH), 7.42 (d, JH,P = 13.73 Hz, 2 H, ArH), 7.22 (d, JH,H
=
3
3
9.16 Hz, 2 H, ArH), 4.12 (dt, JH,H = 7.02, JH,P = 15.57 Hz, 2 H,
CH2O), 3.19 (s, JH,Pt = 19.53 Hz, 4 H, ArCH2), 2.59 [s, JH,Pt
3
3
=
3
18.31 Hz, 12 H, N(CH3)2], 1.10 (t, JH,H = 7.02 Hz, 3 H,
CH3CH2O) ppm. 31P NMR (C6D6): δ = 20.6 (s) ppm. 13C NMR
4
3
(C6D6): δ = 156.1 (d, JC,P = 6.1 Hz, ArC), 144.6 (d, JC,P
=
17.7 Hz, ArC), 144.6 (s, ArC), 127.1, 125.5 (s, ArC), 123.0 (d, 2JC,P
3
1
= 11.6 Hz, ArC), 120.8 (d, JC,P = 4.9 Hz, ArC), 120.6 (d, JC,P
194.1 Hz, ArC), 76.9 (s, JC,Pt = 31.1 Hz, ArCH2N), 62.7 (d, JC,P
= 5.5 Hz, CH2O), 53.8 [s, N(CH3)2], 16.3 (d, JC,P = 6.1 Hz,
=
3
2
3
CH3CH2O) ppm. MS (MALDI-TOF, CSA): m/z = 614.2 [M – Cl]+,
420.1 [M – Cl – Pt]+, 378.3 [M – Cl – Pt – OEt]+. C20H27ClN3O5PPt
(650.95): calcd. C 36.90, H 4.18, N 6.46; found C 37.01, H 4.26, N
6.37.
4-Bromopalladium{3,5-bis[(dimethylamino)methyl]phenyl}phosphonic
Acid (3): A solution of 9 (121 mg, 0.24 mmol) in CH2Cl2 (6 mL)
was treated with of bromotrimethylsilane (362 mg, 312.2 µL,
2.36 mmol, 10 equiv.) and subsequently stirred for 4 h at room tem-
perature. Dry MeOH (10 mL) was added and the resulting yellow
solution was stirred for 1 h. All volatiles were evaporated in vacuo
and the remaining residue was washed with dichloromethane
(2 mL). The crude product was dissolved in a minimum amount of
dry MeOH. Slow addition of diethyl ether precipitated the product
as an off-white solid. Yield: 96 mg (89%). 1H NMR (D2O): δ =
3
7.05 (d, JH,P = 12.6 Hz, 2 H, ArH), 3.96 (s, CH2, 4 H), 2.68 (s,
NMe2, 12 H) ppm. 31P NMR (D2O): δ = 14.83 (s) ppm. 13C NMR
(D2O): δ = 156.4 (s, ArC), 145.9 (d, 3JC,P = 15.4 Hz), 132.8 (d, 1JC,P
[8] a) J. Kjellgren, H. Sundén, K. J. Szabó, J. Am. Chem. Soc.
2005, 127, 1787–1796; b) J. T. Singleton, Tetrahedron 2003, 59,
1837–1857; c) H. P. Dijkstra, M. Q. Slagt, A. McDonald, C. A.
2
= 176.2 Hz, ArC), 122.1 (d, JC,P = 10.4 Hz, ArC), 73.4 (s, CH2),
52.2 [s, N(CH3)2] ppm.
Eur. J. Inorg. Chem. 2008, 4425–4432
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
4431